Colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 18-70 years old; (2) Patients with postoperative pathological stage II/III colorectal cancer who plan to undergo CapeOX chemotherapy regimen; (3) NRS2002 score = 3 points; (4) Conscious and without mental, intellectual, or language communication barriers; (5) Patients and their families are aware of this study and have signed a written informed consent form, capable of completing the questionnaire survey.
Exclusion criteria
Exclusion criteria: (1) Merge mental disorders that cannot withstand research and intervention measures, including those with a history of mental illness or family mental illness, or those who are taking medication to treat mental illnesses; (2) Those who have received neoadjuvant chemotherapy before surgery; (3) Those who merge with other malignant tumors; (4) Merge primary disease individuals who have an impact on the study outcome before the start of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemotherapy tolerance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;Nutritional status;Adverse reactions to chemotherapy; | — |
Countries
China
Contacts
Zunyi Medical University Affiliated Hospital